Literature DB >> 2528980

Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle.

E A Rodrigues1, M P Caruana, A Lahiri, J D Nabarro, H S Jacobs, E B Raftery.   

Abstract

Acromegaly is associated with an increased cardiac morbidity and mortality, but it is not clear whether this is the result of increased incidence of hypertension and coronary heart disease or of a specific disease of heart muscle. Thirty four acromegalic patients were studied by non-invasive techniques. Seven of these patients had raised plasma concentrations of growth hormone at the time of study; three were newly diagnosed and had not received any treatment. Hypertension was present in nine (26%) but only three (9%) had electrocardiographic left ventricular hypertrophy. Echocardiography showed ventricular hypertrophy in 12 (48%) and increased left ventricular mass in 17 (68%) patients. Holter monitoring detected important ventricular arrhythmias in 14 patients. Thallium-201 scanning showed evidence for coronary heart disease in eight patients. Systolic time intervals were normal except when there was coexistent ischaemic heart disease. A comparison between 19 acromegalic patients with no other detectable cause of heart disease and 22 age matched controls showed appreciably abnormal left ventricular diastolic function in the group with acromegaly. The abnormalities shown did not correlate with left ventricular mass or wall thickness. There was no difference in diastolic function between patients with active acromegaly and those with treated acromegaly. Hypertensive acromegalic patients had worse diastolic function than hypertensive controls, suggesting that hypertension may further impair the left ventricular diastolic abnormality in acromegaly. This is the first study to find evidence of subclinical cardiac diastolic dysfunction in acromegaly and it supports the suggestion that there is a specific disease of heart muscle in acromegaly.

Entities:  

Mesh:

Year:  1989        PMID: 2528980      PMCID: PMC1216761          DOI: 10.1136/hrt.62.3.185

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  31 in total

1.  Effect of coronary artery disease and acute myocardial infarction on left ventricular compliance in man.

Authors:  G Diamond; J S Forrester
Journal:  Circulation       Date:  1972-01       Impact factor: 29.690

2.  A point-score system for the ECG diagnosis of left ventricular hypertrophy.

Authors:  D W Romhilt; E H Estes
Journal:  Am Heart J       Date:  1968-06       Impact factor: 4.749

3.  Treadmill stress test in left ventricular hypertrophy.

Authors:  C N Harris; W S Aronow; D P Parker; M A Kaplan
Journal:  Chest       Date:  1973-03       Impact factor: 9.410

4.  Heart muscle disease in acromegaly.

Authors:  C J Pepine; J Aloia
Journal:  Am J Med       Date:  1970-04       Impact factor: 4.965

5.  Mortality in acromegaly.

Authors:  A D Wright; D M Hill; C Lowy; T R Fraser
Journal:  Q J Med       Date:  1970-01

6.  Systolic time intervals in cardiac disease (II).

Authors:  A M Weissler; C L Garrard
Journal:  Mod Concepts Cardiovasc Dis       Date:  1971-02

7.  Influence of left ventricular function and severity of coronary artery disease on exercise-induced pulmonary thallium-201 uptake.

Authors:  A Lahiri; M J O'Hara; M J Bowles; J C Crawley; E B Raftery
Journal:  Int J Cardiol       Date:  1984-04       Impact factor: 4.164

8.  Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension.

Authors:  I Inouye; B Massie; D Loge; N Topic; D Silverstein; P Simpson; J Tubau
Journal:  Am J Cardiol       Date:  1984-01-01       Impact factor: 2.778

9.  Detection of high risk coronary artery disease by thallium imaging.

Authors:  M J O'Hara; A Lahiri; J R Whittington; J C Crawley; E B Raftery
Journal:  Br Heart J       Date:  1985-06

10.  Acromegaly and the heart--echocardiographic and nuclear imaging studies.

Authors:  J C O'Keefe; S J Grant; J C Wiseman; J N Stiel; E G Wilmshurst; R A Cooper; A C Edwards
Journal:  Aust N Z J Med       Date:  1982-12
View more
  17 in total

1.  Doppler echocardiographic patterns in patients with acromegaly.

Authors:  M Terzolo; L Avonto; C Matrella; R Pozzi; S Luceri; G Borretta; F Pecchio; G Ugliengo; G P Magro; G Reimondo
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

Review 2.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

3.  Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues.

Authors:  A Comunello; F Dassie; C Martini; E De Carlo; R Mioni; M Battocchio; A Paoletta; F Fallo; R Vettor; P Maffei
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

Review 4.  Electrophysiological features in acromegaly: re-thinking the arrhythmic risk?

Authors:  M Parolin; F Dassie; R Vettor; R P Steeds; P Maffei
Journal:  J Endocrinol Invest       Date:  2020-07-06       Impact factor: 4.256

Review 5.  Medical consequences of acromegaly: what are the effects of biochemical control?

Authors:  Annamaria Colao; Renata S Auriemma; Rosario Pivonello; Mariano Galdiero; Gaetano Lombardi
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

6.  Cardiovascular effects of high-dose growth hormone treatment in growth hormone-deficient children.

Authors:  R Crepaz; W Pitscheider; G Radetti; C Paganini; L Gentili; G Morini; E Braito; G Mengarda
Journal:  Pediatr Cardiol       Date:  1995 Sep-Oct       Impact factor: 1.655

7.  Relation of endocrine and cardiac findings in acromegalics.

Authors:  G Kahaly; C Stover; J Beyer; S Mohr-Kahaly
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

Review 8.  Acromegalic cardiomyopathy: a review of the literature.

Authors:  M P Matta; P Caron
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

9.  Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly.

Authors:  Muhammet Dural; Giray Kabakcı; Neşe Cınar; Tomris Erbaş; Uğur Canpolat; Kadri Murat Gürses; Lale Tokgözoğlu; Ali Oto; Ergün Barış Kaya; Hikmet Yorgun; Levent Sahiner; Selçuk Dağdelen; Kudret Aytemir
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

Review 10.  Cardiovascular complications in acromegaly: methods of assessment.

Authors:  G Vitale; R Pivonello; M Galderisi; A D'Errico; L Spinelli; G Lupoli; G Lombardi; A Colao
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.